{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:29Z","timestamp":1792118369147,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00689"],"award-info":[{"award-number":["PI21\/00689"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/00103"],"award-info":[{"award-number":["PI24\/00103"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","award":["GCAEC20030CERV"],"award-info":[{"award-number":["GCAEC20030CERV"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008963","name":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ctrv.2025.103015","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:23:53Z","timestamp":1755649433000},"page":"103015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life"],"prefix":"10.1016","volume":"140","author":[{"given":"Marco","family":"Airoldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Tarazona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"P\u00e9rez-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Fleitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pla-Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desamparados","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-3691","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0010","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Can J Clin"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Can J Clin"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43046-025-00277-z","article-title":"Advances in colorectal cancer screening and detection: a narrative review on biomarkers, imaging and preventive strategies","volume":"37","author":"Khan","year":"2025","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103015_b0025","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.3390\/cancers12123611","article-title":"Neoadjuvant chemotherapy in locally advanced rectal cancer","volume":"12","author":"Papaccio","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ctrv.2025.103015_b0030","article-title":"Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"S0923753425007318","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103015_b0035","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ejso.2009.06.010","article-title":"Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas","volume":"35","author":"Li","year":"2009","journal-title":"Eur J Surg Oncol EJSO"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2214\/AJR.11.7602","article-title":"Recognition of the anterior peritoneal reflection at rectal MRI","volume":"200","author":"Gollub","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ctrv.2025.103015_b0045","doi-asserted-by":"crossref","unstructured":"Zhang G, Cai Y zhe, Xu G hui. Diagnostic Accuracy of MRI for Assessment of T Category and Circumferential Resection Margin Involvement in Patients With Rectal Cancer: A Meta-Analysis. Dis Colon Rectum. 2016 Aug;59(8):789\u201399.","DOI":"10.1097\/DCR.0000000000000611"},{"key":"10.1016\/j.ctrv.2025.103015_b0050","article-title":"Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): a long-term prospective, multicentre, cohort study","volume":"6","author":"Kang","year":"2021","journal-title":"Lancet Reg Health - West Pac"},{"key":"10.1016\/j.ctrv.2025.103015_b0055","doi-asserted-by":"crossref","unstructured":"Yoon JH, Lee JM, Chang W, Kang H jin, Bandos A, Lim H ju, et al. Initial M Staging of Rectal Cancer: FDG PET\/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT. Radiology. 2020 Feb;294(2):310\u20139.","DOI":"10.1148\/radiol.2019190794"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00261-024-04460-z","article-title":"FDG-PET\/MRI in colorectal cancer care: an updated systematic review","volume":"50","author":"Lo","year":"2024","journal-title":"Abdom Radiol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0065","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of Metastatic Colorectal Cancer: ASCO Guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.ctrv.2025.103015_b0070","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1200\/JCO.24.01160","article-title":"Management of locally advanced rectal cancer: ASCO guideline","volume":"42","author":"Scott","year":"2024","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ctrv.2025.103015_b0075","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Br\u00e6ndengen","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jss.2024.09.022","article-title":"Role of adjuvant chemotherapy after curative resection in stage II and III rectal cancer","volume":"303","author":"Althans","year":"2024","journal-title":"J Surg Res"},{"key":"10.1016\/j.ctrv.2025.103015_b0090","doi-asserted-by":"crossref","unstructured":"Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer. N Engl J Med. 1997 Apr 3;336(14):980\u20137.","DOI":"10.1056\/NEJM199704033361402"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103015_b0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103015_b0100","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.ctrv.2025.103015_b0105","doi-asserted-by":"crossref","first-page":"12159","DOI":"10.3390\/ijms241512159","article-title":"Total neoadjuvant treatment for locally advanced rectal cancer patients: where do we stand?","volume":"24","author":"Dapr\u00e0","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103015_b0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/cancers17020330","article-title":"A comprehensive approach to neoadjuvant treatment of locally advanced rectal cancer","volume":"17","author":"Gandini","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/jcm14030912","article-title":"Therapeutic management of locally advanced rectal cancer: existing and prospective approaches","volume":"14","author":"Li\u0219cu","year":"2025","journal-title":"J Clin Med"},{"issue":"25","key":"10.1016\/j.ctrv.2025.103015_b0120","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ctrv.2025.103015_b0125","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103015_b0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0140","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA3504","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial","author":"Conroy","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2025.103015_b0145","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.ctrv.2025.103015_b0150","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2025.103015_b0155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/02841860601019413","article-title":"Rectal cancer irradiation. Long course, short course or something else?","volume":"45","author":"Glimelius","year":"2006","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103015_b0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fern\u00e1ndez-Martos","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103015_b0165","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.annonc.2024.07.729","article-title":"Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy","volume":"35","author":"Bercz","year":"2024","journal-title":"Ann Oncol"},{"issue":"34","key":"10.1016\/j.ctrv.2025.103015_b0170","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114291","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO\/ARO\/AIO-12 and the OPRA randomized phase 2 trials","volume":"210","author":"Fokas","year":"2024","journal-title":"Eur J Can"},{"key":"10.1016\/j.ctrv.2025.103015_b0185","doi-asserted-by":"crossref","unstructured":"Rouanet P, Guerrieri M, Lemercier P, Balik E, Cotte E, Spinelli A, et al. A Prospective European Trial Comparing Laparotomy, Laparoscopy, Robotic-Assisted, and Transanal Total Mesorectal Excision Procedures in High-Risk Patients with Rectal Cancer: The RESET Trial. Ann Surg [Internet]. 2024 Sep 12 [cited 2024 Nov 1]; Available from: https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006534.","DOI":"10.1097\/SLA.0000000000006534"},{"key":"10.1016\/j.ctrv.2025.103015_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103985","article-title":"Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: a narrative review and evidence-based algorithm","volume":"186","author":"Borelli","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ags3.12777","article-title":"The current multidisciplinary management of rectal cancer","volume":"8","author":"Bhutiani","year":"2024","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ctrv.2025.103015_b0200","doi-asserted-by":"crossref","unstructured":"Motamedi MAK, Mak NT, Brown CJ, Raval MJ, Karimuddin AA, Giustini D, et al. Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy. Cochrane Colorectal Group, editor. Cochrane Database Syst Rev [Internet]. 2023 Jun 13 [cited 2025 Feb 21];2023(6). Available from: http:\/\/doi.wiley.com\/10.1002\/14651858.CD002198.pub3.","DOI":"10.1002\/14651858.CD002198.pub3"},{"key":"10.1016\/j.ctrv.2025.103015_b0205","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae300","article-title":"Neoadjuvant treatment of rectal cancer: from adjunct to surgery to primary organ sparing treatment","author":"Burger","year":"2024","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103015_b0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12957-021-02415-y","article-title":"A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy","volume":"19","author":"Yu","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0220","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.1016\/j.annonc.2024.08.578","article-title":"509O Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): first results of NO-CUT trial","volume":"35","author":"Amatu","year":"2024","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103015_b0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0235","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3502","article-title":"STAR-TREC phase II: can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?","author":"Bach","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0240","doi-asserted-by":"crossref","first-page":"S1533","DOI":"10.1016\/S0167-8140(24)02236-9","article-title":"1929: Organ preservation in rectal cancer: the GRECCAR12 randomized phase 3 trial (NCT02514278)","volume":"194","author":"Vendrely","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctrv.2025.103015_b0245","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae105","article-title":"Impact of radiotherapy on quality of life in patients with rectal cancer","author":"Tejedor","year":"2024","journal-title":"BJS Open"},{"key":"10.1016\/j.ctrv.2025.103015_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae091","article-title":"Effect of radiotherapy on long-term quality of life in recurrence-free rectal cancer survivors (LaTE study): nationwide inverse probability of treatment-weighted registry-based cohort study and survey","author":"Malik","year":"2024","journal-title":"BJS Open"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103015_b0255","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ijrobp.2009.03.010","article-title":"Late side effects and quality of life after radiotherapy for rectal cancer","volume":"76","author":"Bruheim","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"suppl 2","key":"10.1016\/j.ctrv.2025.103015_b0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1289\/ehp.93101s2109","article-title":"Effect of radiation on the human reproductive system","volume":"101","author":"Ogilvy-Stuart","year":"1993","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ctrv.2025.103015_b0265","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-024-02403-y","article-title":"Is radiotherapy necessary for upper rectal cancer underwent curative resection? a retrospective study of 363 patients","volume":"19","author":"Ma","year":"2024","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","article-title":"Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study","volume":"32","author":"Taylor","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103015_b0280","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ctrv.2025.103015_b0285","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMc2210175","article-title":"Prevalence of mismatch-repair deficiency in rectal adenocarcinomas","volume":"387","author":"Papke","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0290","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7096","article-title":"Long-term outcomes of dMMR\/MSI-H rectal cancer treated with anti\u2013PD-1\u2013based immunotherapy as curative-intent treatment","volume":"22","author":"Yu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"25","key":"10.1016\/j.ctrv.2025.103015_b0295","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair\u2013deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2025.103015_b0300","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3512","article-title":"Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer","author":"Cercek","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103015_b0305","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2468-1253(22)00439-3","article-title":"Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study","volume":"8","author":"Chen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.ctrv.2025.103015_b0310","article-title":"The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives","volume":"3","author":"Gandini","year":"2023","journal-title":"Front Oncol"},{"issue":"15","key":"10.1016\/j.ctrv.2025.103015_b0315","article-title":"The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103015_b0320","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ccell.2024.07.004","article-title":"Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: a randomized clinical trial","volume":"42","author":"Xiao","year":"2024","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103015_b0325","first-page":"474","article-title":"Predictive value of preoperative imaging and postoperative pathology on clinical complete response after neoadjuvant chemoradiation for locally advanced rectal cancer","volume":"18","author":"Xiao","year":"2015","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi Chin J Gastrointest Surg"},{"key":"10.1016\/j.ctrv.2025.103015_b0330","article-title":"A management of patients achieving clinical complete response after neoadjuvant therapy and perspectives: on locally advanced rectal cancer","volume":"14","author":"Liu","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10151-022-02654-5","article-title":"Local tumor regrowth after clinical complete response following neoadjuvant therapy for rectal cancer: what happens when organ preservation falls short","volume":"27","author":"Cerd\u00e1n-Santacruz","year":"2023","journal-title":"Tech Coloproctology"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103015_b0340","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1067\/j.cpradiol.2016.11.011","article-title":"MRI Evaluation of Rectal Cancer: Staging and Restaging","volume":"46","author":"Moreno","year":"2017","journal-title":"Curr Probl Diagn Radiol"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103015_b0345","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ejso.2017.03.010","article-title":"Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"43","author":"De Felice","year":"2017","journal-title":"Eur J Surg Oncol EJSO"},{"key":"10.1016\/j.ctrv.2025.103015_b0350","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmp.2019.03.013","article-title":"Neo-adjuvant chemoradiotherapy response prediction using MRI based ensemble learning method in rectal cancer patients","volume":"62","author":"Shayesteh","year":"2019","journal-title":"Phys Med"},{"issue":"1159","key":"10.1016\/j.ctrv.2025.103015_b0355","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/bjr\/tqae098","article-title":"Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis","volume":"97","author":"He","year":"2024","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctrv.2025.103015_b0360","doi-asserted-by":"crossref","DOI":"10.1093\/gastro\/goae027","article-title":"Can rectal MRI and endorectal ultrasound accurately predict the complete response to neoadjuvant immunotherapy for rectal cancer?","author":"Zhai","year":"2023","journal-title":"Gastroenterol Rep"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103015_b0365","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00330-019-06565-2","article-title":"MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy","volume":"30","author":"Jang","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctrv.2025.103015_b0370","doi-asserted-by":"crossref","unstructured":"Wang Y, Yang L, Bao H, Fan X, Xia F, Wan J, et al. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. Dawson SJ, editor. PLOS Med. 2021 Aug 31;18(8):e1003741.","DOI":"10.1371\/journal.pmed.1003741"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103015_b0375","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.ctrv.2025.103015_b0380","article-title":"Circulating tumour DNA as biomarker for rectal cancer: a systematic review and meta-analyses","volume":"30","author":"Van Rees","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2025.103015_b0385","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-20-4769","article-title":"Clinical impact of presurgery circulating tumor DNA after total neoadjuvant treatment in locally advanced rectal cancer: a biomarker study from the GEMCAD 1402 Trial","volume":"27","author":"Vidal","year":"2021","journal-title":"Clin Can Res"},{"key":"10.1016\/j.ctrv.2025.103015_b0390","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-024-04710-0","article-title":"MRI-based radiomic nomogram for predicting disease-free survival in patients with locally advanced rectal cancer","author":"Liu","year":"2024","journal-title":"Abdom Radiol [Internet]"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0395","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13014-024-02492-9","article-title":"MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer","volume":"19","author":"Boldrini","year":"2024","journal-title":"Radiat Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103015_b0400","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.annonc.2021.08.1752","article-title":"Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer","volume":"32","author":"Yoshino","year":"2021","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0405","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1789032","article-title":"The consensus immunoscore: toward a new classification of colorectal cancer","volume":"9","author":"Lanzi","year":"2020","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103015_b0410","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.23.00586","article-title":"International validation of the immunoscore biopsy in patients with rectal cancer managed by a watch-and-wait strategy","volume":"42","author":"El Sissy","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225001379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225001379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:53:53Z","timestamp":1762016033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737225001379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"alternative-id":["S0305737225001379"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103015","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103015"}}